Martini Jeffrey S

Martini Jeffrey S is listed in filings as Chief Scientific Officer at Palvella Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 9, 2026, including 4 public disclosures. Recent filings connect the profile to Palvella Therapeutics, Inc. (PVLA). The current snapshot covers public activity from Dec 17, 2024 to Feb 9, 2026. Reported amounts are shown as $4.9M to $79.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.